AARP and North Carolina Law Enforcement Unite to Combat Rising Cryptocurrency ATM Scams Bengaluru Land Frenzy Second Airport Plans Spark Property Rush in South West Corridors Creator Content Takes Center Stage at TV Upfronts as Ad Spend Surges Past 44 Billion Taiwan Semiconductor Projects Global Chip Market to Surpass 15 Trillion by 2030 Led by AI and HPC Harrow HROW Surges 117 Nearing 3259 Resistance 20260520 SOLV Energy MWH Delivers Q1 2026 Beat EPS 025 vs 015 Expected Tesla Cybertruck Incident in Texas Raises Questions About Wade Mode Feature Police Report Meta Broadcom Lead 125 Million Semiconductor Research Hub at UCLA QXOs Hostile Bid for Beacon Ignites BuildingProducts Sector Contest Kevin Warsh Faces Tense Federal Reserve Debate Over Interest Rate Cuts Amid Inflation Surge India Plans Major Overhaul of Tax Administration to Ensure Smooth GST Implementation Telecoms CEO Warns of US Dominance in Satellites and AI Highlighting Europes Connectivity Vulnerabilities Japans Role in Fentanyl Smuggling Route Raises Trade and Security Concerns Foresight Ventures Backs PopDEX With 30M to Boost TraderFocused Perpetual DEXs EXLS Q1 2026 Earnings EPS Beat by 62 Amid Solid Execution MBINL Q1 2026 Earnings EPS Surpasses Estimates Preferred Shares Edge Higher Vistance Networks Inc VISN Q1 2026 Earnings EPS Surges Past Estimates with 7094 Surprise Trimble Q1 2026 Earnings EPS Surpasses Estimates as Stock Trades Higher FLS Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Roku Q1 2026 Earnings Strong Profit Beat Signals Operating Discipline Cohen Steers ClosedEnd Opportunity Fund FOF Edges Higher Key Levels in Focus Upbound Group Inc UPBD Posts Modest Gain as Shares Approach Resistance Fractyl Health GUTS Dips Near Key Support After 662 Decline Biotech Volatility Continues Mission Produce AVO Holds Steady Near Support as Trading Volume Remains Subdued Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support Stocks Rebound as Crude Oil Falls on Hopes for a USIran Deal TME Q1 2026 Earnings Slightly Beats Estimates as Shares Rise 45 Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels